A Pilot Study of RISE for Nurse Managers Retreat

February 17, 2026 updated by: AdventHealth
The purpose of this study is to determine the feasibility and acceptability of the RISE for Nurse Managers retreat and its impact on occupational and psychological well-being indicators

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The RISE program is an empirically supported wellbeing intervention for nurses and nurse leaders delivered over 8 or 9 weeks in 90-minute weekly sessions facilitated by a licensed mental health professional. The program themes are Resilience, Insight, Self-Compassion, and Empowerment. This study will be to examine the feasibility and acceptability of delivering the program in a retreat style format over 2.5 days.

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • an employed AdventHealth Nurse Manager
  • a "moderate" or "high" score in burnout equal to ≥17 in the Emotional Exhaustion Domain and/or ≥7 in the Depersonalization Domain on the MBI

Exclusion Criteria:

  • a direct care RN, Nurse Director, Educator, and Executive
  • a "low" score in burnout equal to <17 in the Emotional Exhaustion domain and/or <7 in the Depersonalization domain on the MBI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participant group
Intervention group will attend the RISE Retreat program, which is a 2.5-day retreat-style psychoeducational group program facilitated by licensed mental health professionals (LMHPs)
Behavioral: Intervention Group
Psychoeducational group program designed to impact occupational and psychological indicators including resilience, insight, self-compassion, empowerment, burnout and secondary trauma

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maslach Burnout Inventory - Human Services Survey
Time Frame: Baseline, 1-month follow-up, 3-month follow-up, 6-month follow-up
22-item questionnaire with the following response categories: 0=never, 1=a few times a year or less, 2=once a month or less, 3=a few times a month, 4=once a week, 5=a few times a week, 6=every day. MBI includes 3 dimensions of Burnout: Emotional Exhaustion, Depersonalization, and Personal Accomplishment. There are 9 items included in Emotional Exhaustion and scores can range from 0-54. There are 5 items included in Depersonalization and scores can range from 0-30. There are 8 items included in Personal Accomplishment and scores can range from 0-48. Higher scores on Emotional Exhaustion and Depersonalization and lower scores on Personal Accomplishment are indicative of Burnout
Baseline, 1-month follow-up, 3-month follow-up, 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Employment Status
Time Frame: 12-month post-program
Human Resources Data
12-month post-program
Professional Quality of Life Scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often. PROQOL includes 3 dimensions: Compassion Satisfaction, Burnout, and Secondary Traumatic Stress. Each subscale includes 10 items and scores can range from 10-50. For Burnout and Secondary Traumatic Stress, lower scores are better. Sums of 10-22 = low level, 23-41 = average level, and 42-50=high level of Burnout and Secondary Traumatic Stress. For Compassion Satisfaction, higher scores are better. Sum of 10-22=low level, 23-41=average level, and 42-50=high level of Compassion Satisfaction.
Baseline, 1- and 3-and 6-month follow-up
Brief Resilience Scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree. Sum of items can range from 6-30, which is then divided by 6 to get an average score. Higher score is better, with 1-2.99 = low resilience, 3-4.3 = normal resilience, and 4.31-5.0 = high resilience.
Baseline, 1- and 3-and 6-month follow-up
Self-Reflection and Insight Scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
20-item questionnaire with the following response categories: 1=strongly disagree, 2, 3, 4, 5, 6=strongly agree. Six items are included in Self-Reflection and scores can range from 6-42, with higher scores indicating a greater self-reflection. Six items are included in Insight, and scores can also range from 6-42 with higher scores indicating more Insight.
Baseline, 1- and 3-and 6-month follow-up
Self-Compassion Scale Short Form
Time Frame: Baseline, 1- and 3-and 6-month follow-up
12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always. Scores are added and then averaged. While the average score is to be used comparatively, score 1.0-2.49 is considered low, 2.5-3.5 is considered moderate, and 3.51-5.0 is considered high.
Baseline, 1- and 3-and 6-month follow-up
General Self-Efficacy Scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true. Item scores are added together and then averaged with higher scores indicating more self-efficacy.
Baseline, 1- and 3-and 6-month follow-up
Perceived Stress Scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often. The total score ranges from 0 to 40 with higher scores indicating greater perceived stress.
Baseline, 1- and 3-and 6-month follow-up
Generalized Anxiety Disorder - 2 item scale
Time Frame: Baseline, 1- and 3-and 6-month follow-up
2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is 0 to 6 and a score of 3 or higher suggests possible anxiety.
Baseline, 1- and 3-and 6-month follow-up
Patient Health Questionnaire - 2 item
Time Frame: Baseline, 1- and 3-and 6-month follow-up
2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is from 0 to 6, and a score of 3 or more indicates possible depressed mood.
Baseline, 1- and 3-and 6-month follow-up
Post-Traumatic Growth Inventory
Time Frame: Baseline, 1- and 3-and 6-month follow-up
21-item scale scored using six-point responses: zero ("I did not experience this change as a result of my crisis") to five ("I experienced this change to a very great degree as a result of my crisis"). Total score range is 0 to 105, which higher scores indicating more post traumatic growth.
Baseline, 1- and 3-and 6-month follow-up
Psychological Empowerment Instrument
Time Frame: Baseline, 1- and 3-and 6-month follow-up
12-item measure that assesses empowerment in the workplace using a 7-point Likert response scale. Four aspects are measured: meaning, competence, self-determination, and impact. Total score range from 12 to 84, with higher scores indicating greater psychological empowerment.
Baseline, 1- and 3-and 6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AdventHealth

Investigators

  • Principal Investigator: Amanda T. Sawyer, PhD, AdventHealth

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

October 16, 2026

Study Completion (Estimated)

December 16, 2026

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

December 11, 2025

First Posted (Actual)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2365808

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout

Clinical Trials on Intervention Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe